Obesity Clinical Trial
— LEANOfficial title:
The Lifestyle Changes Through Exercise and Nutrition (LEAN) Project
| Verified date | June 2018 |
| Source | Pennington Biomedical Research Center |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The goal of The LEAN project intervention is to promote weight loss, healthy dietary habits, increased physical activity, improved blood glucose and cholesterol, and weight related quality of life in obese African American adults through a sustainable, technology enhanced, church-based program.
| Status | Completed |
| Enrollment | 97 |
| Est. completion date | September 23, 2017 |
| Est. primary completion date | September 23, 2017 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 75 Years |
| Eligibility |
Inclusion Criteria: - self-identify as African American - a member of a participating church - age 18-75 years old - BMI > 30 - own a mobile phone with text message capabilities - at risk for diabetes (diagnosed nuclear family member or gestational diabetes) or diagnosed with type 2 diabetes - willing to provide written informed consent - willing to change diet, physical activity and weight - able to participate in face-face counselling sessions as scheduled - low to moderate cardiovascular disease risk Exclusion Criteria: - currently participating in a weight loss program - currently using weight loss medication or have lost weight (>10 lbs in last year) - planning to move from the area within the next year - given birth within the past year, are currently pregnant or plan to become pregnant within the next year - planning to have bariatric surgery within 2 years - history of major depression, suicidal behavior or eating disorder - hospitalization for a mental disorder or substance abuse in the last year - have cancer or had cancer within the past 5 years. - serious heart problems such as arrhythmias, cardiomyopathy, congestive heart failure - stroke or heart attack in the last six months - high blood pressure [systolic =160, or diastolic =100] - chronic inflammatory conditions, including but not limited to severe arthritis, lupus, or inflammatory bowel disease - diseases that are life threatening or that can interfere with or be aggravated by exercise or weight loss - unwilling or unable to provide informed consent - physician's or principal investigator's decision to exclude |
| Country | Name | City | State |
|---|---|---|---|
| United States | Pennington Biomedical Research Center | Baton Rouge | Louisiana |
| Lead Sponsor | Collaborator |
|---|---|
| Pennington Biomedical Research Center |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Percent weight loss | Percent weight loss will be calculated at 6 and 12 months. | Month 6 and Year 1 | |
| Secondary | Change in Body Fat Percentage | The participant's body fat percentage is measured using the portable Tanita Body Composition Analyzer (SC-240). | Screening, Month 6 and Year 1 | |
| Secondary | Change in Blood Glucose | The Alere Cholestech LDX® Analyzer is engineered to provide accurate, actionable, and readily accessible glucose testing results. The Cholestech uses fingerstick sampling and small sample size (40µL) that makes results less time consuming and easy to obtain. | Screening, Month 6 and Year 1 | |
| Secondary | Change in Blood Pressure | Blood pressure will be measured using an automatic blood pressure cuff (Omeron, Model BP710 or similar). Participants will rest for approximately 5 minutes prior to blood pressure measurement to ensure accurate at rest reading. | Screening, Month 6 and Year 1 | |
| Secondary | Change in Food Intake | The National Cancer Institute (NCI) fat screener estimates the percentage of energy from fat by asking patients to report the frequency of consuming specific foods over the past 12 months. A standard 7-item fruit and vegetable screener developed by the NCI and National 5 a Day Program grantees asks how often fruit and vegetables were consumed in the past month. | Screening, Month 6 and Year 1 | |
| Secondary | Change in Physical activity | The International Physical Activity Questionnaire (IPAQ) questionnaire is a self-report measure of physical activity. The metabolic equivalent task (MET) minutes in each domain of leisure time activity, that is, sedentary, light, moderate, and vigorous intensity, will be calculated. The IPAQ has been shown to be a reliable and valid measure of physical activity and has been sensitive to changes in physical activity resulting from intervention programs. | Screening, Month 6 and Year 1 | |
| Secondary | Change in Quality of Life | . Each participant's quality of life will be assessed using the Impact of Weight on Quality of Life Survey. | Screening, Month 6 and Year 1 | |
| Secondary | Satisfaction Questionnaire | Each participant's satisfaction with the different elements of the study, including the community health coaches, the intervention, and the text messages, will be measured using a questionnaire developed by the investigators. | Month 6 and Year 1 | |
| Secondary | Change in Blood Cholesterol | The Alere Cholestech LDX® Analyzer is engineered to provide accurate, actionable, and readily accessible cholesterol testing results. The Cholestech uses fingerstick sampling and small sample size (40µL) that makes results less time consuming and easy to obtain. | Screening, Month 6 and Year 1 | |
| Secondary | Change in Pulse | Pulse will be measured using an automatic blood pressure cuff (Omeron, Model BP710 or similar). Participants will rest for approximately 5 minutes prior to pulse measurement to ensure accurate at rest reading. | Screening, Month 6 and Year 1 |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |